213 related articles for article (PubMed ID: 27325858)
1. Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival.
Yuan C; Qian ZR; Babic A; Morales-Oyarvide V; Rubinson DA; Kraft P; Ng K; Bao Y; Giovannucci EL; Ogino S; Stampfer MJ; Gaziano JM; Sesso HD; Buring JE; Cochrane BB; Chlebowski RT; Snetselaar LG; Manson JE; Fuchs CS; Wolpin BM
J Clin Oncol; 2016 Aug; 34(24):2899-905. PubMed ID: 27325858
[TBL] [Abstract][Full Text] [Related]
2. Circulating Metabolites and Survival Among Patients With Pancreatic Cancer.
Yuan C; Clish CB; Wu C; Mayers JR; Kraft P; Townsend MK; Zhang M; Tworoger SS; Bao Y; Qian ZR; Rubinson DA; Ng K; Giovannucci EL; Ogino S; Stampfer MJ; Gaziano JM; Ma J; Sesso HD; Anderson GL; Cochrane BB; Manson JE; Torrence ME; Kimmelman AC; Amundadottir LT; Vander Heiden MG; Fuchs CS; Wolpin BM
J Natl Cancer Inst; 2016 Jun; 108(6):djv409. PubMed ID: 26755275
[TBL] [Abstract][Full Text] [Related]
3. Cigarette Smoking and Pancreatic Cancer Survival.
Yuan C; Morales-Oyarvide V; Babic A; Clish CB; Kraft P; Bao Y; Qian ZR; Rubinson DA; Ng K; Giovannucci EL; Ogino S; Stampfer MJ; Gaziano JM; Sesso HD; Cochrane BB; Manson JE; Fuchs CS; Wolpin BM
J Clin Oncol; 2017 Jun; 35(16):1822-1828. PubMed ID: 28358654
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer.
Rasmussen LS; Yilmaz MK; Falkmer UG; Poulsen LØ; Bøgsted M; Christensen HS; Bojesen SE; Jensen BV; Chen IM; Johansen AZ; Hansen CP; Hasselby JP; Holländer N; Nielsen SE; Andersen F; Bjerregaard JK; Pfeiffer P; Johansen JS
Eur J Cancer; 2021 Feb; 144():72-80. PubMed ID: 33341448
[TBL] [Abstract][Full Text] [Related]
5. Association of prediagnostic vitamin D status with mortality among colorectal cancer patients differs by common, inherited vitamin D-binding protein isoforms.
Gibbs DC; Bostick RM; McCullough ML; Um CY; Flanders WD; Jenab M; Weiderpass E; Gylling B; Gram IT; Heath AK; Colorado-Yohar S; Dahm CC; Bueno-de-Mesquita B; Perez-Cornago A; Trichopoulou A; Tumino R; Kühn T; Fedirko V
Int J Cancer; 2020 Nov; 147(10):2725-2734. PubMed ID: 32391587
[TBL] [Abstract][Full Text] [Related]
6. Prediagnostic body mass index and pancreatic cancer survival.
Yuan C; Bao Y; Wu C; Kraft P; Ogino S; Ng K; Qian ZR; Rubinson DA; Stampfer MJ; Giovannucci EL; Wolpin BM
J Clin Oncol; 2013 Nov; 31(33):4229-34. PubMed ID: 24145341
[TBL] [Abstract][Full Text] [Related]
7. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.
Wolpin BM; Ng K; Bao Y; Kraft P; Stampfer MJ; Michaud DS; Ma J; Buring JE; Sesso HD; Lee IM; Rifai N; Cochrane BB; Wactawski-Wende J; Chlebowski RT; Willett WC; Manson JE; Giovannucci EL; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):82-91. PubMed ID: 22086883
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancer.
McGovern EM; Lewis ME; Niesley ML; Huynh N; Hoag JB
Nutr J; 2016 Feb; 15():17. PubMed ID: 26867933
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741.
Ng K; Sargent DJ; Goldberg RM; Meyerhardt JA; Green EM; Pitot HC; Hollis BW; Pollak MN; Fuchs CS
J Clin Oncol; 2011 Apr; 29(12):1599-606. PubMed ID: 21422438
[TBL] [Abstract][Full Text] [Related]
11. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
Fang F; Kasperzyk JL; Shui I; Hendrickson W; Hollis BW; Fall K; Ma J; Gaziano JM; Stampfer MJ; Mucci LA; Giovannucci E
PLoS One; 2011 Apr; 6(4):e18625. PubMed ID: 21494639
[TBL] [Abstract][Full Text] [Related]
12. Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance).
Yuan C; Sato K; Hollis BW; Zhang S; Niedzwiecki D; Ou FS; Chang IW; O'Neil BH; Innocenti F; Lenz HJ; Blanke CD; Goldberg RM; Venook AP; Mayer RJ; Fuchs CS; Meyerhardt JA; Ng K
Clin Cancer Res; 2019 Dec; 25(24):7497-7505. PubMed ID: 31548349
[TBL] [Abstract][Full Text] [Related]
13. Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.
Fedirko V; Riboli E; Tjønneland A; Ferrari P; Olsen A; Bueno-de-Mesquita HB; van Duijnhoven FJ; Norat T; Jansen EH; Dahm CC; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Racine A; Lukanova A; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Benetou V; Trichopoulos D; Grioni S; Vineis P; Panico S; Palli D; Tumino R; Siersema PD; Peeters PH; Skeie G; Brustad M; Chirlaque MD; Barricarte A; Ramón Quirós J; Sánchez MJ; Dorronsoro M; Bonet C; Palmqvist R; Hallmans G; Key TJ; Crowe F; Khaw KT; Wareham N; Romieu I; McKay J; Wark PA; Romaguera D; Jenab M
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):582-93. PubMed ID: 22278364
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms.
Babic A; Bao Y; Qian ZR; Yuan C; Giovannucci EL; Aschard H; Kraft P; Amundadottir LT; Stolzenberg-Solomon R; Morales-Oyarvide V; Ng K; Stampfer MJ; Ogino S; Buring JE; Sesso HD; Gaziano JM; Rifai N; Pollak MN; Anderson ML; Cochrane BB; Luo J; Manson JE; Fuchs CS; Wolpin BM
Cancer Res; 2016 Dec; 76(24):7160-7167. PubMed ID: 27780823
[TBL] [Abstract][Full Text] [Related]
15. Predicted plasma 25-hydroxyvitamin D and risk of renal cell cancer.
Joh HK; Giovannucci EL; Bertrand KA; Lim S; Cho E
J Natl Cancer Inst; 2013 May; 105(10):726-32. PubMed ID: 23568327
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D-binding protein and pancreatic cancer: a nested case-control study.
Piper MR; Freedman DM; Robien K; Kopp W; Rager H; Horst RL; Stolzenberg-Solomon RZ
Am J Clin Nutr; 2015 Jun; 101(6):1206-15. PubMed ID: 25904602
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.
Drake MT; Maurer MJ; Link BK; Habermann TM; Ansell SM; Micallef IN; Kelly JL; Macon WR; Nowakowski GS; Inwards DJ; Johnston PB; Singh RJ; Allmer C; Slager SL; Weiner GJ; Witzig TE; Cerhan JR
J Clin Oncol; 2010 Sep; 28(27):4191-8. PubMed ID: 20713849
[TBL] [Abstract][Full Text] [Related]
18. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer.
Ng K; Meyerhardt JA; Wu K; Feskanich D; Hollis BW; Giovannucci EL; Fuchs CS
J Clin Oncol; 2008 Jun; 26(18):2984-91. PubMed ID: 18565885
[TBL] [Abstract][Full Text] [Related]
19. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.
Stolzenberg-Solomon RZ; Vieth R; Azad A; Pietinen P; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2006 Oct; 66(20):10213-9. PubMed ID: 17047087
[TBL] [Abstract][Full Text] [Related]
20. Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies.
Bao Y; Ng K; Wolpin BM; Michaud DS; Giovannucci E; Fuchs CS
Br J Cancer; 2010 Apr; 102(9):1422-7. PubMed ID: 20389298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
